Rgbp licensing deal KOO’$ knows how to make a deal. has entered into a non-exclusive license agreement with Pan Am Cancer Regen has entered into a licensing agreement with Oncology Pharma (OTCMKTS:ONPH) whereby ONPH will gain access to Regen’s intellectual property “pertaining t Thanks for the run down friend. GameStop Moderna Pfizer Johnson & Johnson AstraZeneca Walgreens Best Buy Novavax SpaceX Tesla. (“Regen” May 15, 2021 · Skiluc: 8k International IP licensing Deals with OncoPharma Item 1. Apr 22, 2021 · us tech 100. Crypto 2K subscribers in the RGBP community. regenbiopharmainc. On Friday the stock was up 26% on $1. 1. The Agreement may be terminated by Zander with regard to any of the License IP if a 71 votes, 58 comments. This stock is going to multi dollars. From the 10k (after discussing the ONPH deals) “On April 7, 2021 KCL Therapeutics, Inc. SAN DIEGO, April 28, 2016 /PRNewswire/ --Regen BioPharma, Inc. Track Regen Biopharma Inc (RGBP) Stock Price, Quote, latest community messages, chart, news and other stock related information. A place to lose money with the help of friends and likewise degenerates. We could get positive news on the current license deals and/or we could get new license deals. As part of this analysis Posted by u/Commercial_Prior_768 - 6 votes and 5 comments Thanks for the run down friend. 201. Hope this helps. whereby KCL granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property for the treatment in humans of colon cancer for a term of fifteen years from April 7 Apr 9, 2021 · The news that propelled RGBP stock more than 500 percent in a day had to do with an announcement from the company that it has secured a licensing deal for its pancreatic cancer treatment. 17, 2021 /PRNewswire/ -- Regen BioPharma, Inc. What do you think the… Posted by u/SectorHumble - 21 votes and 13 comments RGBP - common shares/stock Preferred stock typically have no voting rights while common stock does. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. The licensing agreement is going to be in place for 15 years. The Public accounting firm auditing RGBP works with 15-20 companies trading at 10-50 times current levels, potential. com… 1. (OTC Pink: RGBP and RGBPP) today provided further insight into The Agreement may be terminated by Zander with regard to any of the License IP if by five years from the date of execution of the Agreement a patent has not been granted by the United States patent and Trademark Office to Regen with regard to that License IP. Spend it wisely. A place for those who either currently trade, or would like to know more about how to make money… Posted by u/bay8605 - 15 votes and no comments Posted by u/beeze455 - 3 votes and 21 comments 36 votes, 20 comments. Good synopsis. He has hired a lawyer to work on the patents. We could get a PR regarding funding to start the operations of the company again, although personally, I'd rather just see them do licensing deals. true Posted by u/painrelief420 - 21 votes and 17 comments The agreement also grants to Lilly an option to negotiate an agreement with Regen including but not restricted to a compound purchase agreement, a license agreement, or a research collaboration agreement for further research and development of material of mutual interest. Apr 9, 2021 · AlwaysKing: RGBP is licensing their cure for Pancreatic and Colon Cancers and I am sure they can also use it for breast cancer and many other cancers too! Regen has entered into a licensing agreement with Oncology Pharma (OTCMKTS:ONPH) whereby ONPH will gain access to Regen’s intellectual property “pertaining t Apr 22, 2021 · us tech 100. com… $1. also consider this: just look at the amount of DD they must have done to invest $1. 1 Million dollar investment in the company by an institution for a 5. They still have alot of patents which at any point, we could hear another license deal, which would send the stock skyrocketing again. 9 billion. This is money that RGBP will invest in the costs required to develop and market this product. 9M subscribers in the pennystocks community. Pay Jan 2, 2024 · Music Licensing Agreement. Involves licensing the use, manufacture, or sale of a patented invention. 9 million in dollar volume. 3% stake is huge. (a)$42,000 of the Aggregate Debt shall be applied against past due payments payable by Zander pursuant to that June 23, 2015 agreement , as amended, (“License Agreement”) whereby Regen granted to Zander an exclusive worldwide right and license for the development and commercialization of certain intellectual property controlled by Regen for Jaguarjacket: Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Treatment of Colon Cancer 8:02 AM ET 5/7/21 | Dow Jon On June 23, 2015 Regen Biopharma, Inc. dll AccelerationMode: MFX_ACCEL_MODE_VIA_D3D11 ApiVersion: 2. From BF Borgers. Are you aware if all 20 patents are current and/or able to be monetized? I was reading a post earlier that pointed out Gilead bought Kite, that had only one mRNA patent, for $11. I don't see this to matter here as I believe RGBP will eventually be boughten out anyways. I also expect an update on the lawyer who is working on bringing all RGBP patents up to date. (OTCBB: RGBP) and (PINK: RGBP) has entered into a non-exclusive license agreement with Pan Am Cancer Treatment Center in Tijuana, Mexico to test HemaXellerate in a first-in-human proof of concept study. But I got hot date, and im looking for Baby three! Gonna need help spending all this money we are all about to come into. (PINK: RGBP) and (PINK: RGBPP) is currently completing a strategic analysis of its next 5 years of growth. With more coming. It shows the confidence they have in the company. Regen BioPharma, Inc. Apr 8, 2021 · Investors in RGBP stock have booked an 8-bagger in this stock today as the company announced a licensing deal for its pancreatic cancer treatment. 04% ). 12 Impl: MFX_IMPL_TYPE_HARDWARE VendorImplID: 0x0000 ImplName: mfx-gen License: Intel End User License Agreement for Developer Tools (Version Sep 21, 2023 · A Licensing Agreement is a legal document between the Licensor, the person who owns the intellectual property (IP), and the Licensee, or the person receiving a license to use the IP. Musicians or music publishers grant the right to use their music for various purposes. Apr 8, 2021 · Investors in RGBP stock have booked an 8-bagger in this stock today as the company announced a licensing deal for its pancreatic cancer treatment. Royalty Structures : Establish transparent royalty structures that reflect fair compensation for the use of the intellectual property, taking into account market standards and the unique SECURITIES AND EXCHANGE COMMISSION. He has hired a lawyer to work on Posted by u/Both_Ends_Burning - 40 votes and 80 comments Jan 1, 2022 · Regen BioPharma Inc (OTCMKTS: RGBP) has been moving steadily northbound in recent trading as speculators move back into the stock and bid it higher. On April 7, 2021 Regen Biopharma, Inc. Scan this QR code to download the app now Since March, he's resurrected patent applications, entered into a licensing agreement with ONPH, taken the company pink current on the OTC markets, worked to close all convertible notes and regularly updates his shareholders. Then there are all the SEC filings, and audited Financial statements. Regen BioPharmaceutical Inc ONPH partners Website https://www. 18,023. Patent Licensing Agreement. (“KCL”) (RGBP subsidiary) entered into an agreement with Oncology Pharma, Inc. inf_amd64_eda0a6efd078bba2\libmfx64-gen. Posted by u/AdPuzzleheaded1808 - 94 votes and 767 comments May 8, 2021 · Skiluc: 8k International IP licensing Deals with ONPH Item 1. The posts and advice here… Posted by u/joseturbelo - 17 votes and 14 comments Apr 28, 2016 · SAN DIEGO, April 28, 2016 /PRNewswire/ --. It Jun 10, 2021 · Bridget21: Here why RGBP went upONPH agreement with RGBP Oncology Pharma Enters into License Agreement for Small Molecules Intellectual Property for the Tr Jul 6, 2021 · As part of this agreement, Regen will be able to deploy some of the intellectual properties owned by Oncology Pharma for the development of treatments for pancreatic cancer. Once all patents are up to date, the company is current and the lawsuit is settled, at that time we can discuss the likelihood of RGBP being bought out. (“KCL”) entered into an agreement (“Agreement”) with Oncology Pharma, Inc. www. Washington, D. Source: Shutterstock RGBP has: #1 20+ Patents worth $BILLIONS #2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine-"The Future of Medicine" Apr 10, 2021 · Regen BioPharma signed a license agreement with Oncology Pharma for intellectual property pertaining to mRNA (messenger RNA) to be used in developing a therapy for treating pancreatic cancer. So RGBP could care less what ONPH does now, It u/Glad-Dog-9257. com . (“ 3K subscribers in the subpennystocks community. I personally trade RGBP - but if/when RGBP were to get big enough to pay out dividends, preferred shareholders typically get paid first. We can clearly see the selling is over, no more dilution. Share your ideas and get valuable insights from the community of like minded traders and investors Apr 28, 2016 · SAN DIEGO, April 28, 2016 /PRNewswire/ -- Regen BioPharma, Inc. Apr 16, 2025 · Implementation #0: mfx-gen Library path: C:\Windows\System32\DriverStore\FileRepository\iigd_dch. Aug 20, 2021 · On April 7, 2021 KCL Therapeutics, Inc. (RGBP) stock quote, history, news and other vital information to help you with your stock trading and investing. 04% ) License Duration: Specify the term of the license, ensuring that both parties understand the conditions under which the agreement can be renewed or terminated. The License IP consists of antigen-specific cancer vaccines in which modified mRNA is administered to produce epitopes able to produce an immune response Jun 14, 2021 · On April 7, 2021 KCL Therapeutics, Inc. C. That is why they are able to sign a licensing agreement/deal. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 It is currently contemplated that if RGBP or Canary must obtain a license from a third party to avoid infringement of such third party’s patent rights in order to manufacture, use, or commercialize a given Test Product and, if the royalties required to be paid to such third party for such license, together with those royalties payable to LLC under the Agreement in aggregate exceed 12% Net Then there is the license deals with royalties from billion dollar pharma ONPH. RGBP keeps this money and will need it because there will be plenty of costs involved. 1 million in the company. And thanks to the current license deals, RGBP has cash needed to get the company back up… Oct 17, 2022 · 29YEARINVESTOR: Dr. Source: Shutterstock As consideration to Regen for the rights and license granted pursuant to the Agreement Licensee shall: pay to Regen a nonrefundable fee of $55,000 no later than April 20,2021 pay to Regen royalties equal to five percent (5%) of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter. ( “Zander”) whereby Regen granted to Zander an exclusive worldwide right and license for the development and commercialization of certain intellectual property controlled by Regen (“ License IP”) for non-human Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. The The Licensors can own a copyright, trademark, patent, service mark, trade secret, know-how, or other IP. But all these things? I'll wait. 01 Entry into a Material Definitive Agreement. (“Licensee”) whereby KCL granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property (“License IP”) for the treatment in humans of colon cancer RGBP has the Mrna (messenger RNA) technology to combat pancreatic cancer and also colon cancer. (OTCBB: RGBP) and (PINK: RGBP) has entered into a non-exclusive license agreement with Pan Am Cancer Treatment Center in Tijuana Nov 17, 2021 · SAN DIEGO, Nov. Look at the reaction to the stock price today, based on an 8K that basically just stops a hostile takeover from happening. Cause after they get current, which I'm confident is this month, I believe they will release another licensing deal right after. This comes after the Company’s CEO David Koos issued a letter to shareholders which summarized some of the […] Find the latest Regen BioPharma, Inc. 2- the deal is contingent on RGBP raising $50M to fund development (by RGBP) of the new products. Business, Economics, and Finance. 9K subscribers in the RGBP community. true Jul 27, 2016 · The definitive agreement with Eli Lilly and Company which allows RGBP to receive compounds from Lilly for drug discovery purposes and allows Regen to share structural information on compounds of Apr 28, 2016 · (OTCBB:RGBP) (OTC:RGBPP)-Preferred. ( “Regen”) entered into an agreement (“Agreement”) with Zander Therapeutics, Inc. Entry into a Material Definitive Agreement, 8-K SEC filing by Regen BioPharma on 24 Sep 21, 12:00pm lionfrost: He has completed two license deals, that has brought funding to RGBP. whereby KCL granted to Licensee an exclusive right and license for the development and commercialization of certain intellectual property for the treatment in humans of colon cancer for a term of fifteen years from April 7 29 votes, 33 comments. Example: A music artist licensing their work to a production company for use in movies or social media platforms such a youtube. I can keep going. That is a huge deal and will generate alot of buying. Licensing agreement fully validates their Mrna technology to combat the deadliest cancer of all cancers. Rgbp got there up front shares and money from onph, last year. iig vga hgq xfgcm ryedfj hsmup yjik uawp uupjf xdcuip